Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Co-existing mental and somatic conditions in Swedish children with the avoidant restrictive food intake disorder phenotype

View ORCID ProfileMarie-Louis Wronski, View ORCID ProfileRalf Kuja-Halkola, View ORCID ProfileElin Hedlund, View ORCID ProfileMiriam I. Martini, View ORCID ProfilePaul Lichtenstein, Sebastian Lundström, View ORCID ProfileHenrik Larsson, View ORCID ProfileMark J. Taylor, View ORCID ProfileNadia Micali, View ORCID ProfileCynthia M. Bulik, View ORCID ProfileLisa Dinkler
doi: https://doi.org/10.1101/2024.03.10.24304003
Marie-Louis Wronski
aDepartment of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden
bNeuroendocrine Unit, Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA
cTranslational Developmental Neuroscience Section, Division of Psychological and Social Medicine and Developmental Neurosciences, Faculty of Medicine, TU Dresden, Dresden, Germany
MSc
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Marie-Louis Wronski
Ralf Kuja-Halkola
aDepartment of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Ralf Kuja-Halkola
Elin Hedlund
aDepartment of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden
BA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Elin Hedlund
Miriam I. Martini
aDepartment of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden
MSc
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Miriam I. Martini
Paul Lichtenstein
aDepartment of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Paul Lichtenstein
Sebastian Lundström
dGillberg Neuropsychiatry Centre, Institute of Neuroscience and Physiology, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Henrik Larsson
aDepartment of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden
eSchool of Medical Sciences, Örebro University, Örebro, Sweden
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Henrik Larsson
Mark J. Taylor
aDepartment of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Mark J. Taylor
Nadia Micali
fCenter for Eating and Feeding Disorders Research, Mental Health Center Ballerup, Copenhagen University Hospital – Mental Health Services CPH, Denmark
gInstitute for Biological Psychiatry, Mental Health Centre Sct Hans, Copenhagen University Hospital – Mental Health Services, Copenhagen, Denmark
hGreat Ormond Street Institute of Child Health, University College London, London, United Kingdom
MD, PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Nadia Micali
Cynthia M. Bulik
aDepartment of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden
iDepartment of Psychiatry, University of North Carolina at Chapel Hill, NC, USA
jDepartment of Nutrition, University of North Carolina at Chapel Hill, NC, USA
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Cynthia M. Bulik
Lisa Dinkler
aDepartment of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Lisa Dinkler
  • For correspondence: lisa.dinkler{at}ki.se
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Abstract

Background Avoidant restrictive food intake disorder (ARFID) is a feeding and eating disorder, characterized by limited variety and/or quantity of food intake impacting physical health and psychosocial functioning. Children with ARFID often present with a range of psychiatric and somatic symptoms, and therefore consult various pediatric subspecialties; large-scale studies mapping comorbidities are however lacking. To characterize health care needs of people with ARFID, we systematically investigated ARFID-related mental and somatic conditions in 616 children with ARFID and >30,000 children without ARFID.

Methods In a Swedish twin cohort, we identified the ARFID phenotype in 6–12-year-old children based on parent-reports and register data. From >1,000 diagnostic ICD-codes, we specified mental and somatic conditions within/across ICD-chapters, number of distinct per-person diagnoses, and inpatient treatment days between birth and 18th birthday (90 outcomes). Hazard ratios (HR) and incidence rate ratios (IRR) were calculated.

Findings Relative risks of neurodevelopmental, gastrointestinal, endocrine/metabolic, respiratory, neurological, and allergic disorders were substantially increased in ARFID (e.g., autism HR[CI95%]=9.7[7.5–12.5], intellectual disability 10.3[7.6–13.9], gastroesophageal reflux disease 6.7[4.6–9.9], pituitary conditions 5.6[2.7–11.3], chronic lower respiratory diseases 4.9[2.4–10.1], epilepsy 5.8[4.1–8.2]). ARFID was not associated with elevated risks of autoimmune illnesses and obsessive-compulsive disorder. Children with ARFID had a significantly higher number of distinct mental diagnoses (IRR[CI95%]=4.7[4.0–5.4]) and longer duration of hospitalizations (IRR[CI95%]=5.5[1.7–17.6]) compared with children without ARFID. Children with ARFID were diagnosed earlier with a mental condition than children without ARFID. No sex-specific differences emerged.

Interpretation This study yields the broadest and most detailed evidence of co-existing mental and somatic conditions in the largest sample of children with ARFID to date. Findings suggest a complex pattern of health needs in youth with ARFID, underscoring the critical importance of attention to the illness across all pediatric specialties.

Funding Fredrik and Ingrid Thurings Foundation, Mental Health Foundation.

Evidence before the study Avoidant restrictive food intake disorder (ARFID) is an eating and feeding disorder that often develops in childhood and that is associated with co-existing conditions such as anxiety; depression; and endocrine/metabolic, gastrointestinal, and immunological disorders. We systematically searched Embase, including Medline, and PubMed databases using the terms (“avoidant restrictive food intake disorder” OR “ARFID”) AND (“comorbidity” OR ((“co-existing” OR “comorbid” OR “concurrent” OR “co-occurring”) AND (“concern” OR “condition” OR “disorder” OR “illness” OR “problem”))) in title and abstract without language restrictions. Our search yielded 86 studies from 2013, when ARFID was first introduced as a diagnosis in DSM-5: most of these studies have been conducted in relatively small clinical samples, did not have a control group, or covered a limited range of mental and/or somatic conditions that often were reported as concerns rather than formal diagnoses. Further, we identified one systematic review (published in 2023) applying a more extensive search algorithm with similar terms, which reported that psychiatric comorbidity was common in ARFID, especially anxiety disorders (9–72%) and autism (8–55%). However, knowledge regarding medical treatment needs in ARFID is sparse; and potential effects of sex and age on co-existing conditions in ARFID throughout childhood and adolescence are unstudied, except for one study comparing comorbidities in 23 preschool vs. 28 school children with ARFID (published in 2023). The lack of large-scale studies on comorbidities in ARFID contributes to diagnostic misclassification and treatment delays, ultimately interfering with appropriate medical care.

Added value of this study This cohort study, based on high-quality Swedish Twin Registry data, utilized the, to our knowledge, largest sample of children and adolescents with ARFID (n=616) and without ARFID (controls, n=30,179) to date. We applied a large-scale approach to study a broad range of mental and somatic diagnoses, received in both inpatient and outpatient settings, from birth to 18th birthday (or until censored). In addition to confirming previous evidence of frequently co-occurring conditions such as attention deficit hyperactivity disorder, autism, and gastrointestinal disorders in a larger sample, we demonstrated that ARFID is associated with an increased risk of a wide variety of perinatal and congenital conditions (e.g., fetal growth retardation; perinatal jaundice and infections; circulatory, digestive, and nervous system malformations), allergic and respiratory conditions (e.g., acute and chronic lower and upper respiratory disorders), and psychiatric and neurodevelopmental disorders (e.g., tic disorders; conduct disorders; developmental disorders of motor function, speech and language, and scholastic skills). Furthermore, our study revealed greater treatment needs in children with ARFID compared with controls, indicated by higher number of distinct per-person diagnoses and longer duration of inpatient treatment due to any mental or somatic diagnosis (accumulated over time). Moreover, mental conditions were more likely to be diagnosed at an earlier age in children with AFRID relative to controls. However, this study did not yield relevant effects of sex assigned at birth on relative risk of any analyzed condition in ARFID vs. controls.

Implications of all the available evidence Given the range and novelty of analyzed mental and somatic conditions, this study may generate hypotheses for future basic, epidemiological, and clinical research on the etiology, clinical presentation, and consequences of ARFID. Combined with previous evidence, we reveal the heterogenous and complex clinical presentations of the ARFID phenotype in childhood and adolescence. ARFID and its co-existing conditions require attention in the medical practice of multiple specialties (e.g., general pediatrics, pediatric endocrinology and gastroenterology, child and adolescent psychiatry, pediatric emergency care, family/internal medicine, and general practice) in order to develop multimodal diagnostic and treatment guidelines that improve treatment options for children and adolescents with ARFID.

Competing Interest Statement

Henrik Larsson has received grants from Shire/Takeda; personal fees from Medici, Evolan, and Shire/Takeda outside the submitted work; and is Editor-in-Chief of JCPP Advances. Cynthia M. Bulik receives royalties from Pearson outside the submitted work. Lisa Dinkler has received personal fees from Baxter Medical AB and Fresenius Kabi AB outside the submitted work. All other authors did not report any biomedical or financial conflicts of interest.

Funding Statement

Marie-Louis Wronski was supported by the Endocrine Society (REGMS program/Research Experiences for Graduate and Medical Students); the Else Kroener-Fresenius Foundation (structured doctoral program); and the German National Academic Scholarship Foundation. Cynthia M. Bulik was supported by NIMH (R56MH129437; R01MH120170; R01MH124871; R01MH119084; R01MH118278; R01MH124871); Swedish Research Council (Vetenskapsradet, award: 538-2013-8864); Lundbeck Foundation (Grant no. R276-2018-4581). Lisa Dinkler was supported by the Swedish Mental Health Foundation (Fonden foer Psykisk Haelsa); and grant 2021-00660 from the Fredrik and Ingrid Thurings Foundation. The funders had no role in the design/conduct of the study, data management/analysis, or manuscript preparation.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

The study was conducted in accordance with the Helsinki Declaration. The Regional Ethical Review Board in Stockholm, Sweden (Dnr 03-672, 2010/597-31/1, 2010/322-31/2) gave ethical approval for this work. Informed assent was obtained from all human subjects in this study.

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.

Yes

Data Availability

Swedish register data are not publicly available and cannot be shared. However, for transparency of the applied analyses, the authors share their analysis script (available on Github [open access]: https://github.com/MarieLouisW/Co-existing-mental-and-somatic-conditions-in-avoidant-restrictive-food-intake-disorder.git).

https://github.com/MarieLouisW/Co-existing-mental-and-somatic-conditions-in-avoidant-restrictive-food-intake-disorder.git

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Back to top
PreviousNext
Posted March 15, 2024.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Co-existing mental and somatic conditions in Swedish children with the avoidant restrictive food intake disorder phenotype
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Co-existing mental and somatic conditions in Swedish children with the avoidant restrictive food intake disorder phenotype
Marie-Louis Wronski, Ralf Kuja-Halkola, Elin Hedlund, Miriam I. Martini, Paul Lichtenstein, Sebastian Lundström, Henrik Larsson, Mark J. Taylor, Nadia Micali, Cynthia M. Bulik, Lisa Dinkler
medRxiv 2024.03.10.24304003; doi: https://doi.org/10.1101/2024.03.10.24304003
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Co-existing mental and somatic conditions in Swedish children with the avoidant restrictive food intake disorder phenotype
Marie-Louis Wronski, Ralf Kuja-Halkola, Elin Hedlund, Miriam I. Martini, Paul Lichtenstein, Sebastian Lundström, Henrik Larsson, Mark J. Taylor, Nadia Micali, Cynthia M. Bulik, Lisa Dinkler
medRxiv 2024.03.10.24304003; doi: https://doi.org/10.1101/2024.03.10.24304003

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Pediatrics
Subject Areas
All Articles
  • Addiction Medicine (349)
  • Allergy and Immunology (668)
  • Allergy and Immunology (668)
  • Anesthesia (181)
  • Cardiovascular Medicine (2648)
  • Dentistry and Oral Medicine (316)
  • Dermatology (223)
  • Emergency Medicine (399)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (942)
  • Epidemiology (12228)
  • Forensic Medicine (10)
  • Gastroenterology (759)
  • Genetic and Genomic Medicine (4103)
  • Geriatric Medicine (387)
  • Health Economics (680)
  • Health Informatics (2657)
  • Health Policy (1005)
  • Health Systems and Quality Improvement (985)
  • Hematology (363)
  • HIV/AIDS (851)
  • Infectious Diseases (except HIV/AIDS) (13695)
  • Intensive Care and Critical Care Medicine (797)
  • Medical Education (399)
  • Medical Ethics (109)
  • Nephrology (436)
  • Neurology (3882)
  • Nursing (209)
  • Nutrition (577)
  • Obstetrics and Gynecology (739)
  • Occupational and Environmental Health (695)
  • Oncology (2030)
  • Ophthalmology (585)
  • Orthopedics (240)
  • Otolaryngology (306)
  • Pain Medicine (250)
  • Palliative Medicine (75)
  • Pathology (473)
  • Pediatrics (1115)
  • Pharmacology and Therapeutics (466)
  • Primary Care Research (452)
  • Psychiatry and Clinical Psychology (3432)
  • Public and Global Health (6527)
  • Radiology and Imaging (1403)
  • Rehabilitation Medicine and Physical Therapy (814)
  • Respiratory Medicine (871)
  • Rheumatology (409)
  • Sexual and Reproductive Health (410)
  • Sports Medicine (342)
  • Surgery (448)
  • Toxicology (53)
  • Transplantation (185)
  • Urology (165)